Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain BEAT message board posts where the ticker symbol BEAT has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest BEAT SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000039 Size: 15 KB
2018-05-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000038 Size: 4 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000037 Size: 4 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000036 Size: 4 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000035 Size: 5 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000034 Size: 4 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000033 Size: 4 KB
2018-05-08
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000032 Size: 5 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000031 Size: 8 KB
2018-05-08
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001574774-18-000030 Size: 12 KB
2018-05-04
More BEAT SEC Filings


Related news from
Fri, 25 May 2018
11:30:00 +0000
Complimentary Technical Snapshots on Bruker and Three More Medical Research Stocks
Research reports have been issued by WallStEquities.com on BioTelemetry Inc. (NASDAQ: BEAT), Bruker Corp. (NASDAQ: BRKR), Cancer Genetics Inc. (NASDAQ: CGIX), and Check-Cap Ltd (NASDAQ: CHEK). Companies in the Medical Laboratories and Research category is very small from a dividend perspective.
Mon, 21 May 2018
18:00:12 +0000
Analyzing BEAT, SUPN, ADBE And RHT Stocks
BioTelemetry’s (BEAT) net income has declined at a 3-year and 5-year average of 17% and 5.9% respectively. The company’s negative pre-tax margin changed from 5.5% in 2013 to 3.6% in 2017. The stock prices have beaten the diagnostics & research industry and S&P 500 between 2013 and 2017. The market cap had gained 373% between 2013 and 2017.
Mon, 21 May 2018
16:30:02 +0000
Total Returns and Sector Exposure for Growth Indexes—Continued
The S&P 900 Growth and S&P 900 Pure Growth indexes have three-year annualized returns of 13% and 9.7%, respectively. They have five-year annualized returns of 15% and 12.7%, respectively. They have YTD (year-to-date) returns of 5.4% and 6.1%, respectively.
Wed, 09 May 2018
14:26:20 +0000
America's top fund is run by a father-son duo from the shores of Lake Minnetonka
The best performing mutual fund so far this year - beating the S&P 500 by more than 20% - is run by a small-town duo of father and son.
Fri, 27 Apr 2018
13:15:01 +0000
Tech Rally Ends NASDAQ's 5-Day Slide
Tech Rally Ends NASDAQ's 5-Day Slide
Fri, 27 Apr 2018
11:30:00 +0000
Consolidated Research: 2018 Summary Expectations for AdvanSix, Flagstar, CalAmp, Agree Realty, Cowen Group, and BioTelemetry — Fundamental Analysis, Key Performance Indications
NEW YORK, April 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Thu, 26 Apr 2018
09:06:45 +0000
Edited Transcript of BEAT earnings conference call or presentation 25-Apr-18 9:00pm GMT
Q1 2018 BioTelemetry Inc Earnings Call
Wed, 25 Apr 2018
21:32:28 +0000
BioTelemetry: 1Q Earnings Snapshot
On a per-share basis, the Malvern, Pennsylvania-based company said it had net income of 17 cents. Earnings, adjusted for one-time gains and costs, came to 39 cents per share. The results beat Wall Street ...
Wed, 25 Apr 2018
20:05:00 +0000
BioTelemetry, Inc. Reports First Quarter 2018 Financial Results
MALVERN, Pa., April 25, 2018-- BioTelemetry, Inc., the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of ...
Thu, 19 Apr 2018
14:37:56 +0000
BioTelemetry, Inc. to Release First Quarter 2018 Earnings Results on April 25, 2018
MALVERN, Pa., April 19, 2018-- BioTelemetry, Inc. will release its first quarter 2018 earnings on Wednesday, April 25 at 4:00 PM Eastern Time.. The BioTelemetry quarterly conference call will be held at ...
Mon, 09 Apr 2018
20:54:21 +0000
Healthcare and biotech investor Sami Hamade dies
Hamade had spent the past three-plus years as a partner with New York-based Apple Tree Partners.
Mon, 26 Mar 2018
19:21:11 +0000
Edited Transcript of BEAT earnings conference call or presentation 22-Feb-18 10:00pm GMT
Q4 2017 BioTelemetry Inc Earnings Call
Fri, 23 Mar 2018
18:59:51 +0000
BioTelemetry, Inc. (Nasdaq: BEAT) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its 10th Listing Anniversary
What: BioTelemetry, Inc. will visit the Nasdaq MarketSite in Times Square in celebration of its 10th listing anniversary. BioTelemetry, Inc. is the leading wireless medical technology company focused on ...
Mon, 19 Mar 2018
12:00:36 +0000
What Analysts Recommend for Amedisys and Peers in March 2018
Amedisys (AMED) is a healthcare services company with a focus on providing home care through three segments: home health, hospice, and personal care. Of the 11 analysts covering Amedisys in March 2018, three analysts have given the stock a “strong buy” rating. Two analysts have given the stock a “buy” rating, while six analysts have given it a “hold” rating.
Tue, 06 Mar 2018
19:27:40 +0000
A Look at BioTelemetry’s Financial Performance
Here's What's in Store for BioTelemetry in 2018
Tue, 06 Mar 2018
19:27:39 +0000
Understanding BioTelemetry’s Business Strategy
BioTelemetry’s (BEAT) business strategy is to solidify its position as a leading provider of outpatient cardiac monitoring services, expand in the research market, and leverage its monitoring platform in new markets. In order to increase the demand for its portfolio of outpatient cardiac monitoring solutions, BioTelemetry is focusing on educating cardiologists, electrophysiologists, and neurologists on the benefits of using mobile cardiac telemetry for arrhythmia monitoring while stressing the increased diagnostic yield and ability to deliver more effective treatments.
Tue, 06 Mar 2018
19:27:39 +0000
Analyst Ratings for BioTelemetry and Its Peers in March 2018
BioTelemetry (BEAT) provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. In July 2017, BioTelemetry acquired LifeWatch, a supplier of mobile cardiac monitoring solutions. The acquisition is expected to help BioTelemetry create a comprehensive connected healthcare platform and deliver solutions in the market more effectively.
Tue, 06 Mar 2018
19:27:39 +0000
Exploring BioTelemetry’s Segments
BioTelemetry (BEAT) operates in three segments: healthcare, research, and technology. The healthcare segment contributed 81% of BioTelemetry’s total revenues in fiscal 2017. Under this segment, BioTelemetry offers a full spectrum of solutions with a single source of cardiac monitoring services to cardiologists, electrophysiologists, neurologists, and primary care physicians.
Tue, 06 Mar 2018
13:23:01 +0000
BioTelemetry (BEAT) Beats Q4 Earnings and Revenue Estimates
BioTelemetry (BEAT) sees strong Q4 results, courtesy of solid acquisitions and promising performance by the MCT platform.
Thu, 01 Mar 2018
12:45:00 +0000
Analysis: Positioning to Benefit within Bluerock Residential Growth REIT, National Presto Industries, Healthways, Deluxe, BioTelemetry, and Modine Manufacturing — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum has been a life changer for me. Due to the generosity of a remarkable group of people I quit work at the age of 53 to invest/trade full time. ValueForum is like having a thousand set of eyes watching the markets for you, there is no way an individual working alone could begin to keep up with all the information that as a member of this group you are able to keep up with. Take my right arm but don't take my ValueForum!" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards